Literature DB >> 18813799

Inhibition of Stearoyl-CoA Desaturase 1 expression in human lung adenocarcinoma cells impairs tumorigenesis.

Natalia Scaglia1, R Ariel Igal.   

Abstract

Saturated (SFA) and monounsaturated (MUFA) fatty acids, the most abundant fatty acid species, have many divergent biological effects including the regulation of cell proliferation, programmed cell death and lipid-mediated cytotoxicity. Their distribution is regulated by Stearoyl-CoA Desaturases (SCD), the enzymes that convert SFA into MUFA. A positive correlation between high levels of tissue MUFA and several types of cancer has been reported, but a causal relationship between the function of SCD1, the main human SCD isoform, and cancer development has not yet been firmly established. Here we report that the stable knockdown of SCD1 gene expression in A549 human lung adenocarcinoma cells decreased the ratio MUFA/SFA in total lipids and inhibited the incorporation of glucose into cell lipids. Cell proliferation and anchorage-independent growth were considerably decreased in SCD1-depleted cells, whereas the rate of apoptosis was elevated, with respect to control A549 cells. In addition, phosphorylation of Akt-Ser473 and GSK-3beta-Ser9 was found notably impaired in SCD1-ablated A549 cells. Interestingly, the effects of SCD1 blockade on Akt activation, cancer cell growth and apoptosis could not be reversed by exogenously added oleic acid. Remarkably, the reduction of SCD1 expression in lung cancer cells significantly delayed the formation of tumors and reduced the growth rate of tumor xenografts in mice. Our study demonstrates that SCD1 activity regulates Akt activation and determines the rate of cell proliferation, survival and invasiveness in A549 cancer cells and shows, for the first time, that SCD1 is a key factor in the regulation of tumorigenesis in vivo.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18813799

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  65 in total

1.  Abrogation of de novo lipogenesis by stearoyl-CoA desaturase 1 inhibition interferes with oncogenic signaling and blocks prostate cancer progression in mice.

Authors:  Vanessa Fritz; Zohra Benfodda; Geneviève Rodier; Corinne Henriquet; François Iborra; Christophe Avancès; Yves Allory; Alexandre de la Taille; Stéphane Culine; Hubert Blancou; Jean Paul Cristol; Françoise Michel; Claude Sardet; Lluis Fajas
Journal:  Mol Cancer Ther       Date:  2010-06-08       Impact factor: 6.261

2.  Genetic variants within ultraconserved elements and susceptibility to right- and left-sided colorectal adenocarcinoma.

Authors:  Moubin Lin; Cathy Eng; Ernest T Hawk; Maosheng Huang; Anthony J Greisinger; Jian Gu; Lee M Ellis; Xifeng Wu; Jie Lin
Journal:  Carcinogenesis       Date:  2012-02-08       Impact factor: 4.944

Review 3.  Features of the Phosphatidylinositol Cycle and its Role in Signal Transduction.

Authors:  Richard M Epand
Journal:  J Membr Biol       Date:  2016-06-08       Impact factor: 1.843

4.  Deficiency of stearoyl-CoA desaturase-1 aggravates colitogenic potential of adoptively transferred effector T cells.

Authors:  Beng San Yeoh; Piu Saha; Vishal Singh; Xia Xiao; Yun Ying; Jairam K Vanamala; Mary J Kennett; Kevin J Harvatine; Bina Joe; Matam Vijay-Kumar
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-09-08       Impact factor: 4.052

5.  Chronic exposure to chewing tobacco selects for overexpression of stearoyl-CoA desaturase in normal oral keratinocytes.

Authors:  Vishalakshi Nanjappa; Santosh Renuse; Gajanan J Sathe; Remya Raja; Nazia Syed; Aneesha Radhakrishnan; Tejaswini Subbannayya; Arun Patil; Arivusudar Marimuthu; Nandini A Sahasrabuddhe; Rafael Guerrero-Preston; Babu L Somani; Bipin Nair; Gopal C Kundu; T Keshava Prasad; Joseph A Califano; Harsha Gowda; David Sidransky; Akhilesh Pandey; Aditi Chatterjee
Journal:  Cancer Biol Ther       Date:  2015-09-21       Impact factor: 4.742

Review 6.  Stearoyl-coenzyme A desaturase 1 inhibition and the metabolic syndrome: considerations for future drug discovery.

Authors:  J Mark Brown; Lawrence L Rudel
Journal:  Curr Opin Lipidol       Date:  2010-06       Impact factor: 4.776

7.  Targeting stearoyl-CoA desaturase 1 to repress endometrial cancer progression.

Authors:  Weihua Li; Huimin Bai; Shiping Liu; Dongyan Cao; Hongying Wu; Keng Shen; Yanhong Tai; Jiaxin Yang
Journal:  Oncotarget       Date:  2018-01-24

8.  Inhibition of stearoylCoA desaturase activity blocks cell cycle progression and induces programmed cell death in lung cancer cells.

Authors:  Daniel Hess; Jeffrey W Chisholm; R Ariel Igal
Journal:  PLoS One       Date:  2010-06-30       Impact factor: 3.240

9.  High stearoyl-CoA desaturase 1 expression is associated with shorter survival in breast cancer patients.

Authors:  Ashley M Holder; Ana M Gonzalez-Angulo; Huiqin Chen; Argun Akcakanat; Kim-Anh Do; W Fraser Symmans; Lajos Pusztai; Gabriel N Hortobagyi; Gordon B Mills; Funda Meric-Bernstam
Journal:  Breast Cancer Res Treat       Date:  2012-12-04       Impact factor: 4.872

10.  Inhibition of stearoylCoA desaturase-1 inactivates acetyl-CoA carboxylase and impairs proliferation in cancer cells: role of AMPK.

Authors:  Natalia Scaglia; Jeffrey W Chisholm; R Ariel Igal
Journal:  PLoS One       Date:  2009-08-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.